LYTIX — Lytix Biopharma AS Share News
0.000.00%
Last trade - 00:00- NOK634.84m
- NOK564.68m
Brief: Lytix Biopharma Appoints Marie Roskrow As Chairman
Brief: Lytix Biopharma Q4 Loss NOK 29.2 Million
Brief: Lytix Biopharma Q3 Loss Narrows To NOK 11.1 Mln
05 Study To Europe
Brief: Lytix Biopharma Q2 Loss Narrows To NOK 1.2 Mln
04 Trial In Patients With Metastatic Soft Tissue Sarcoma (Sts)
Brief: Lytix Biopharma Q1 Loss Widens To NOK 15.2 Million